Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason N Berman

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Cancers|June 24, 2022
Low-Dose Metronomic Topotecan and Pazopanib (TOPAZ) in Children with Relapsed or Refractory Solid Tumors: A C17 Canadian Phase I Clinical TrialArif Manji, Yvan Samson, Rebecca J Deyell, et al.
Cells|April 13, 2023
S1P1 Threonine 236 Phosphorylation Mediates the Invasiveness of Triple-Negative Breast Cancer and Sensitivity to FTY720Fabrice J F Laroche, Sheng Li, Ning Shen, et al.
Leukemia|August 13, 2024
Loss of Dnajc21 leads to cytopenia and altered nucleotide metabolism in zebrafishSarada Ketharnathan, Sujata Pokharel, Sergey V Prykhozhij, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|October 13, 2017
hace1 Influences zebrafish cardiac development via ROS-dependent mechanismsBabak Razaghi, Shelby L Steele, Sergey V Prykhozhij, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|December 6, 2024
tp53 R217H and R242H mutant zebrafish exhibit dysfunctional p53 hallmarks and recapitulate Li-Fraumeni syndrome phenotypesKim Kobar, Lissandra Tuzi, Jennifer A Fiene, et al.
Science Translational Medicine|December 16, 2014
Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenaseYan Liu, Aarti Asnani, Lin Zou, et al.
Archives of Pathology & Laboratory Medicine|August 21, 2019
Pathologic Features of Down Syndrome Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML0431Kelley J Mast, Jeffrey W Taub, Todd A Alonzo, et al.
Cancer Research Communications|July 10, 2025
Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision TherapyNadine Azzam, Jamie I Fletcher, Nicole Melong, et al.
Blood|April 9, 2017
Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trialJeffrey W Taub, Jason N Berman, Johann K Hitzler, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 3, 2023
Tissue-Engineered Disease Modeling of Lymphangioleiomyomatosis Exposes a Therapeutic Vulnerability to HDAC InhibitionAdam Pietrobon, Julien Yockell-Lelièvre, Nicole Melong, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Cancers|June 24, 2022
Low-Dose Metronomic Topotecan and Pazopanib (TOPAZ) in Children with Relapsed or Refractory Solid Tumors: A C17 Canadian Phase I Clinical TrialArif Manji, Yvan Samson, Rebecca J Deyell, et al.
Cells|April 13, 2023
S1P1 Threonine 236 Phosphorylation Mediates the Invasiveness of Triple-Negative Breast Cancer and Sensitivity to FTY720Fabrice J F Laroche, Sheng Li, Ning Shen, et al.
Leukemia|August 13, 2024
Loss of Dnajc21 leads to cytopenia and altered nucleotide metabolism in zebrafishSarada Ketharnathan, Sujata Pokharel, Sergey V Prykhozhij, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|October 13, 2017
hace1 Influences zebrafish cardiac development via ROS-dependent mechanismsBabak Razaghi, Shelby L Steele, Sergey V Prykhozhij, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|December 6, 2024
tp53 R217H and R242H mutant zebrafish exhibit dysfunctional p53 hallmarks and recapitulate Li-Fraumeni syndrome phenotypesKim Kobar, Lissandra Tuzi, Jennifer A Fiene, et al.
Science Translational Medicine|December 16, 2014
Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenaseYan Liu, Aarti Asnani, Lin Zou, et al.
Archives of Pathology & Laboratory Medicine|August 21, 2019
Pathologic Features of Down Syndrome Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML0431Kelley J Mast, Jeffrey W Taub, Todd A Alonzo, et al.
Cancer Research Communications|July 10, 2025
Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision TherapyNadine Azzam, Jamie I Fletcher, Nicole Melong, et al.
Blood|April 9, 2017
Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trialJeffrey W Taub, Jason N Berman, Johann K Hitzler, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 3, 2023
Tissue-Engineered Disease Modeling of Lymphangioleiomyomatosis Exposes a Therapeutic Vulnerability to HDAC InhibitionAdam Pietrobon, Julien Yockell-Lelièvre, Nicole Melong, et al.
Pageof 11